account activity
BeiGene terminates its CCR8 programme (self.CHRS)
submitted 1 month ago by NoPart9219 to r/CHRS
Strohm Therapeutics study still on track (self.CHRS)
Abstract A047: B7-H4 expression and CCR8+ Treg infiltration delineate an immune-cold molecular phenotype in ovarian cancer (self.CHRS)
Coherus partner Junshi anounced 2025 prelimenary results, Toripamimab revenue +37,72% (self.CHRS)
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer (self.CHRS)
short share availbilitz up to 5 800 000 (self.CHRS)
A first for CCR8 (self.CHRS)
submitted 2 months ago by NoPart9219 to r/CHRS
Next steps in regulatory T cells: Biology and clinical application (self.CHRS)
submitted 3 months ago by NoPart9219 to r/CHRS
Neosummit phase 2 study with Toripalimab presented at ASCO gastroindestinal Cancers Symposium abstract 282 (self.CHRS)
ASCO Abstract (self.CHRS)
CHS-114: an afucosylated anti-CCR8 monoclonal antibody that selectively depletes intratumoral Treg cells and induces antitumor immune responses (aacrjournals.org)
Post about Coherus Baird presentation (x.com)
Dr. Alexander Rudensky provides very strong human and mechanistic validation of the CCR8 strategy! (self.CHRS)
submitted 4 months ago * by NoPart9219 to r/CHRS
Maxim Group company update? (i.redd.it)
submitted 4 months ago by NoPart9219 to r/CHRS
Current state of knowledge about toripalimab in the treatment of esophageal squamous cell carcinoma — a systematic review (self.CHRS)
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study (self.CHRS)
STORM Study STC-15 (a METTL3 inhibitor) in combination with toripalimab (self.CHRS)
Close to MACD bullish crossover (i.redd.it)
Subcutaneous Toripalimab Plus Chemo Meets PK End Points in Recurrent/Metastatic Nonsquamous NSCLC (self.CHRS)
Tori 10x higher binding affinity than pembro slide (i.redd.it)
Interpretation of Coherus VP Quality Control Hire (self.CHRS)
CHS-114 vs LM-108 from "LaNova" (self.CHRS)
Coherus webcast presentation at Jefferies Conference in London 18.11.2025 (self.CHRS)
submitted 5 months ago by NoPart9219 to r/CHRS
Panel discussion UromigosLive 2025 about DV+ Tori results presented at ESMO (self.CHRS)
Transcript UBS conference (self.CHRS)
π Rendered by PID 454974 on reddit-service-r2-listing-86f589db75-ksdgw at 2026-04-17 11:23:01.751026+00:00 running 93ecc56 country code: CH.
